Page last updated: 2024-09-05

monoisoamyl-2,3-dimercaptosuccinate and captopril

monoisoamyl-2,3-dimercaptosuccinate has been researched along with captopril in 1 studies

Compound Research Comparison

Studies
(monoisoamyl-2,3-dimercaptosuccinate)
Trials
(monoisoamyl-2,3-dimercaptosuccinate)
Recent Studies (post-2010)
(monoisoamyl-2,3-dimercaptosuccinate)
Studies
(captopril)
Trials
(captopril)
Recent Studies (post-2010) (captopril)
5301910,3201,514890

Protein Interaction Comparison

ProteinTaxonomymonoisoamyl-2,3-dimercaptosuccinate (IC50)captopril (IC50)
Leukotriene A-4 hydrolaseHomo sapiens (human)3.6
Angiotensin-converting enzyme Homo sapiens (human)0.084
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.0173
Succinyl-diaminopimelate desuccinylaseHaemophilus influenzae Rd KW203.3
Angiotensin-converting enzymeRattus norvegicus (Norway rat)0.1004
Beta-lactamase Pseudomonas aeruginosa5
Angiotensin-converting enzyme 2 Homo sapiens (human)0.011
Beta-lactamase class B VIM-2 Pseudomonas aeruginosa3.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flora, SJ; Mehta, A; Mishra, D; Pachauri, V; Saxena, G1

Other Studies

1 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and captopril

ArticleYear
Combinational chelation therapy abrogates lead-induced neurodegeneration in rats.
    Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2

    Topics: Animals; Antioxidants; Apoptosis; Behavior, Animal; Biogenic Amines; Calcium; Captopril; Chelating Agents; Cytochromes c; Disease Models, Animal; DNA Damage; Drug Therapy, Combination; Exploratory Behavior; Lead Poisoning, Nervous System; Learning; Male; Membrane Potential, Mitochondrial; Memory; Mitochondria; Motor Activity; Nerve Degeneration; Neurons; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer

2009